These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 8239247

  • 21. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications.
    Abdul-Rauf A, Gauderer M, Chiarucci K, Berman B.
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):342-5. PubMed ID: 7583391
    [Abstract] [Full Text] [Related]

  • 22. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
    Bedoya MA, Raffini L, Durand R, Acord MR, Srinivasan A, Krishnamurthy G, Vatsky S, Escobar F, Cahill AM.
    Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
    [Abstract] [Full Text] [Related]

  • 23. Morbidity associated with long-term use of totally implantable ports in patients with AIDS.
    Domingo P, Fontanet A, Sánchez F, Allende L, Vazquez G.
    Clin Infect Dis; 1999 Aug; 29(2):346-51. PubMed ID: 10476740
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of infectious complications of the implantable venous access system in a general oncologic population.
    Chang L, Tsai JS, Huang SJ, Shih CC.
    Am J Infect Control; 2003 Feb; 31(1):34-9. PubMed ID: 12548255
    [Abstract] [Full Text] [Related]

  • 25. Peripheral venous access ports: outcomes analysis in 109 patients.
    Bodner LJ, Nosher JL, Patel KM, Siegel RL, Biswal R, Gribbin CE, Tokarz R.
    Cardiovasc Intervent Radiol; 2000 Feb; 23(3):187-93. PubMed ID: 10821892
    [Abstract] [Full Text] [Related]

  • 26. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections.
    Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J.
    Ann Intern Med; 2004 Jan 06; 140(1):18-25. PubMed ID: 14706968
    [Abstract] [Full Text] [Related]

  • 27. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F, Jean-Laurent M, Boulanger L, El Bédoui S, Mallet Y, Houpeau JL, Hamdani A, Penel N, Fournier C.
    Eur J Surg Oncol; 2011 Oct 06; 37(10):913-8. PubMed ID: 21831566
    [Abstract] [Full Text] [Related]

  • 28. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I, Davis S, Becker M, Hohn D, Houston D, Umphrey J, Bodey GP.
    Arch Intern Med; 1993 Aug 09; 153(15):1791-6. PubMed ID: 8392831
    [Abstract] [Full Text] [Related]

  • 29. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K, Hammarskjöld F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S.
    Br J Anaesth; 2019 Jun 09; 122(6):734-741. PubMed ID: 31005243
    [Abstract] [Full Text] [Related]

  • 30. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias.
    Jean G, Charra B, Chazot C, Vanel T, Terrat JC, Hurot JM, Laurent G.
    Nephron; 2002 Jul 09; 91(3):399-405. PubMed ID: 12119469
    [Abstract] [Full Text] [Related]

  • 31. Patient preferences and willingness to pay for central venous access devices in breast cancer: A multicenter discrete choice experiment.
    Liu S, Xiang Y, Gu Y, Chen N, Fu P, Wei Y, Zhao P, Li Y, Du C, Mu W, Xia Z, Chen Y.
    Int J Nurs Stud; 2024 Apr 09; 152():104695. PubMed ID: 38301304
    [Abstract] [Full Text] [Related]

  • 32. Peripheral insertion of a central venous access device under fluoroscopic guidance using a peripherally accessed system (PAS) port in the forearm.
    Hata Y, Morita S, Morita Y, Awatani T, Takasaki M, Horimi T, Ozawa Z.
    Cardiovasc Intervent Radiol; 1998 Apr 09; 21(3):230-3. PubMed ID: 9626440
    [Abstract] [Full Text] [Related]

  • 33. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
    Voog E, Campion L, du Rusquec P, Bourgeois H, Domont J, Denis F, Emmanuel E, Dupuis O, Ganem G, Lafont C, Le Du K, Pavluc E, Pointreau Y, Roche S, Juhel-Voog L, Zinger M, Solal-Celigny P.
    Support Care Cancer; 2018 Jan 09; 26(1):81-89. PubMed ID: 28756472
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bacteremia and fungemia in cancer patients with venous catheters.
    Kukucková E, Studená M, Trupl J, Svec J, Kunová A, Sufliarsky J, Sorkovská D, Minárik T, Sycová Z, Krcméry V.
    Neoplasma; 1995 Jan 09; 42(1):35-8. PubMed ID: 7617073
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.